Haigan Yang1,2†
Zheshen Li1
Zhuoxun Wu1Xiang Chen1
Letao Bo1
Harsh Patel1Bohan Zhang1
Wenjun Xiong2
Wei Wang2*
Zhe-Sheng Chen1*- 1Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John’s University, Queens, NY, United States
- 2The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China
A Correction on
Reversal of ABCG2-mediated drug resistance by tinodasertib (ETC-206)
by Yang H, Li Z, Wu Z, Chen X, Bo L, Patel H, Zhang B, Xiong W, Wang W and Chen Z-S (2025). Front. Pharmacol. 16:1606857. doi: 10.3389/fphar.2025.1606857
An incorrect Funding statement was provided. The funder’s name and number were incorrect. The correct funding statement reads:
The author(s) declare that financial support was received for the research and/or publication of this article. This research was supported by the Scientific Research Project of the Guangdong Provincial Administration of Traditional Chinese Medicine (Grant No. 20231125).
The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: ATP-binding cassette (ABC) transporter, tinodasertib, ETC-206, ABCG2, multidrug resistance (MDR)
Citation: Yang H, Li Z, Wu Z, Chen X, Bo L, Patel H, Zhang B, Xiong W, Wang W and Chen Z-S (2025) Correction: Reversal of ABCG2-mediated drug resistance by tinodasertib (ETC-206). Front. Pharmacol. 16:1648210. doi: 10.3389/fphar.2025.1648210
Received: 16 June 2025; Accepted: 21 July 2025;
Published: 07 August 2025.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2025 Yang, Li, Wu, Chen, Bo, Patel, Zhang, Xiong, Wang and Chen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Wei Wang, d2FuZ3dlaTE2NDAwQDE2My5jb20=; Zhe-Sheng Chen, Y2hlbnpAc3Rqb2hucy5lZHU=
†Present Address: Haigan Yang, Guangzhou University of Chinese Medicine, Guangzhou, China